Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 35% ± 21% | |
astrocyte | 7 studies | 29% ± 11% | |
plasmacytoid dendritic cell | 7 studies | 20% ± 6% | |
endothelial cell | 3 studies | 26% ± 6% | |
GABAergic neuron | 3 studies | 54% ± 7% | |
interneuron | 3 studies | 32% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 31% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 7100.38 | 2638 / 2642 | 99% | 10.38 | 696 / 705 |
adrenal gland | 20% | 86.52 | 51 / 258 | 77% | 2.66 | 176 / 230 |
thymus | 71% | 366.50 | 465 / 653 | 16% | 0.28 | 98 / 605 |
uterus | 66% | 339.39 | 112 / 170 | 8% | 0.16 | 38 / 459 |
ovary | 66% | 306.59 | 119 / 180 | 8% | 0.11 | 34 / 430 |
prostate | 40% | 187.20 | 98 / 245 | 17% | 0.24 | 85 / 502 |
heart | 53% | 267.99 | 459 / 861 | 0% | 0 | 0 / 0 |
pancreas | 31% | 127.36 | 101 / 328 | 6% | 0.28 | 10 / 178 |
kidney | 12% | 47.42 | 11 / 89 | 22% | 0.35 | 194 / 901 |
breast | 15% | 61.28 | 69 / 459 | 6% | 0.10 | 64 / 1118 |
adipose | 15% | 63.04 | 185 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 4% | 16.34 | 59 / 1445 | 8% | 0.13 | 14 / 183 |
bladder | 10% | 36.81 | 2 / 21 | 2% | 0.05 | 11 / 504 |
lung | 4% | 15.58 | 22 / 578 | 6% | 0.10 | 70 / 1155 |
stomach | 2% | 7.47 | 8 / 359 | 2% | 0.03 | 6 / 286 |
skin | 1% | 3.66 | 18 / 1809 | 2% | 0.03 | 10 / 472 |
liver | 1% | 4.69 | 3 / 226 | 1% | 0.02 | 5 / 406 |
intestine | 1% | 4.86 | 11 / 966 | 1% | 0.05 | 6 / 527 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.06 | 1 / 45 |
blood vessel | 1% | 6.33 | 17 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.04 | 1 / 80 |
muscle | 1% | 2.52 | 5 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.63 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042448 | Biological process | progesterone metabolic process |
GO_0006707 | Biological process | cholesterol catabolic process |
GO_0006699 | Biological process | bile acid biosynthetic process |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_1903044 | Biological process | protein localization to membrane raft |
GO_1900271 | Biological process | regulation of long-term synaptic potentiation |
GO_0016125 | Biological process | sterol metabolic process |
GO_0007399 | Biological process | nervous system development |
GO_0098793 | Cellular component | presynapse |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0098794 | Cellular component | postsynapse |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0030425 | Cellular component | dendrite |
GO_0062184 | Molecular function | testosterone 16-beta-hydroxylase activity |
GO_0033781 | Molecular function | cholesterol 24-hydroxylase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0008395 | Molecular function | steroid hydroxylase activity |
GO_0020037 | Molecular function | heme binding |
Gene name | CYP46A1 |
Protein name | Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1) Cytochrome P450 family 46 subfamily A member 1 |
Synonyms | CYP46 |
Description | FUNCTION: P450 monooxygenase that plays a major role in cholesterol homeostasis in the brain. Primarily catalyzes the hydroxylation (with S stereochemistry) at C-24 of cholesterol side chain, triggering cholesterol diffusion out of neurons and its further degradation . By promoting constant cholesterol elimination in neurons, may activate the mevalonate pathway and coordinate the synthesis of new cholesterol and nonsterol isoprenoids involved in synaptic activity and learning (By similarity). Further hydroxylates cholesterol derivatives and hormone steroids on both the ring and side chain of these molecules, converting them into active oxysterols involved in lipid signaling and biosynthesis . Acts as an epoxidase converting cholesta-5,24-dien-3beta-ol/desmosterol into (24S),25-epoxycholesterol, an abundant lipid ligand of nuclear NR1H2 and NR1H3 receptors shown to promote neurogenesis in developing brain . May also catalyze the oxidative metabolism of xenobiotics, such as clotrimazole . . |
Accessions | ENST00000261835.8 [Q9Y6A2-1] ENST00000556313.1 H0YJU5 G3V366 H0YJI0 ENST00000554917.5 ENST00000554611.5 Q9Y6A2 ENST00000380228.6 [Q9Y6A2-2] |